The amyloid protein precursor (APP) is also expressed more strongly in the granulocytes of AD patients compared to controls, whereas there was no statistically significant difference in the lymphocyte and mononuclear cell populations, suggesting that the strong expression of APP in peripheral mononuclear cells could be used for the early diagnosis of AD (48). This evidence concerns the gene APP and Alzheimer disease.